Saturday 17 October 2026
Export DMAC’s income statement to Excel — free account
DiaMedica Therapeutics, Inc.
DMAC Healthcare Biotechnology
In the quarter to June 2026, EPS fell 5.56%, free cash flow fell 6.75% and total debt fell 90.0%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
7.57
0.47
−5.85%
Follow DMAC
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | — |
+8 more quarters Free account |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
6.63 | 8.98 | 11.72 | 10.55 | |
Current Ratio |
6.72 | 9.11 | 11.81 | 10.67 | |
Net Debt/EBITDA |
4.08 | 4.81 | 6.33 | 5.97 | |
Debt/Assets |
0.00% | 0.00% | 0.01% | 0.01% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.80 | 0.90 | 0.89 | 0.76 | |
Capex/Depreciation |
0.02 | 0.04 | 0.02 | 0.07 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.15) | (0.17) | (0.17) | (0.13) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.15) | (0.17) | (0.17) | (0.13) | |
Cash per Share |
0.81 | 0.95 | 1.27 | 1.11 | |
Shareholders Equity per Share |
0.71 | 0.88 | 1.19 | 1.04 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.71 | 0.88 | 1.19 | 1.04 | |
Free Cash Flow |
(8.12) | (9.09) | (7.77) | (6.57) | |
Working Capital |
37.72 | 46.62 | 55.50 | 50.96 | |
Capital Expenditures |
0.00 | (0.01) | (0.01) | (0.02) | |
Net Current Asset Value |
37.65 | 46.52 | 55.37 | 50.80 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
0.20 | 0.28 | 0.25 | 0.28 | |
Average Payables |
2.04 | 2.40 | 1.21 | 1.55 | |
Average Assets |
38.24 | 45.96 | 53.86 | 54.79 | |
Average Common Equity |
32.75 | 40.59 | 48.41 | 49.79 |
Columns are period end dates